Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination

Background: Immune protection following either vaccination or infection with SARS-CoV-2 decreases over time. Objective: We aim to describe clinical and sociodemographic characteristics associated with COVID-19 infection at least 14 days after booster vaccination in the Israeli population. Methods: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Israel, Ariel, Merzon, Eugene, Shenhar, Yotam, Green, Ilan, Golan-Cohen, Avivit, Schäffer, Alejandro A., Ruppin, Eytan, Vinker, Shlomo, Magen, Eli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145987/
https://www.ncbi.nlm.nih.gov/pubmed/35632392
http://dx.doi.org/10.3390/vaccines10050636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145987/
https://www.ncbi.nlm.nih.gov/pubmed/35632392
http://dx.doi.org/10.3390/vaccines10050636

Ejemplares similares